Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof

Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof

US Patent 11203601 · Granted Dec 21, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses the2025
Dopamine D2 receptor ligands2025
Dopamine D2 receptor ligands2025
Dopamine D2 receptor ligands2025
Kinase inhibitors and methods of use thereof2025
Kinase inhibitors and methods of use thereof2025